The second trimester Doppler ultrasound examination is the best predictor of late pregnancy outcome in systemic lupus erythematosus and/or the antiphospholipid syndrome

Rheumatology

Volumn 45, Issue 3, 2006, Pages 332-338

  Le Thi Huong, D ^a   Wechsler, B ^a   Vauthier Brouzes, D ^a   Duhaut, P ^a   Costedoat, N ^a   Andreu, M R ^a   Lefebvre, G ^a   Piette, J C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antiphospholipid syndrome; Doppler ultrasound; Pregnancy; Systemic lupus erythematosus

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; IMMUNOGLOBULIN; STEROID;

ADULT; ANALYSIS OF VARIANCE; ANAMNESIS; ANTIPHOSPHOLIPID SYNDROME; ARTERY BLOOD FLOW; ARTICLE; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; EMBRYO DEATH; FEMALE; FETUS DEATH; FETUS GROWTH; FRAGILITY FRACTURE; GROWTH INHIBITION; HELLP SYNDROME; HUMAN; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PREDICTION; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; SEPTICEMIA; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOPHLEBITIS; THROMBOSIS; UMBILICAL ARTERY; UTERINE ARTERY;

ANTIPHOSPHOLIPID SYNDROME; FEMALE; FETAL DEATH; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; THROMBOPHLEBITIS; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL; UMBILICAL ARTERIES;

EID: 33644865455     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kei159     Document Type: Article

References (31)

1. Petri M, Howard D, Repke J, Goldman DW. The Hopkins Lupus Pregnancy Center: 1987-1991 Update. Am J Reprod Immunol 1992;28:188-91.
2. Lima F, Khamashta MA, Buchanan NMM, Kerslake S, Hunt BJ, Hughes GRV. A study of sixty pregnancies in patients with the antiphospholipid syndrome. Clin Exp Rheumatol 1996;14:131-6.
3. Silver RK, McGregor DO, Sholl JS, Hobart JM, Neerhof DO, Ragin A. Comparative trial of prednisone plus aspirin versus aspirin alone in the treatment of anticardiolipin antibody-positive obstetric patient. Am J Obstet Gynecol 1993;169:1411-17.
4. Branch DW, Peaceman AM, Druzin M et al. for the Pregnancy Loss Study Group. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. Am J Obstet Gynecol 2000;182:122-7.
5. Chavez M, Guzman ER, Benito C, Yeo L, Vintzileos A. The clinical significance of absence of end-diastolic velocities of the umbilical artery detected in the severely preterm fetus. Obstet Gynecol 2001; 97:S45.
6. Mires GJ, Williams FL, Leslie J, Howie PW. Assessment of uterine arterial notching as a screening test for adverse pregnancy outcome. Am J Obstet Gynecol 1998;179:1317-23.
7. Kofinas AD, Penry M, Simon NV, Swain M. Interrelationship and clinical significance of increased resistance in the uterine arteries in patients with hypertension or pre-eclampsia or both. Am J Obstet Gynecol 1992;166;601-6.
8. North RA, Ferrier C, Long D, Townend K, Kincaid-Smith P. Uterine artery Doppler flow velocity waveforms in the second trimester for the prediction of pre-eclampsia and fetal growth retardation. Obstet Gynecol 1994;83:378-86.
9. Rahman P, Gladman DD, Urowitz MB. Clinical predictors of fetal outcome in systemic lupus erythematosus. J Rheumatol 1998;25: 1526-30.
10. Jungers P, Dougados M, Pelissier C et al. Lupus nephropathy and pregnancy: Report of 104 cases in 36 patients. Arch Intern Med 1982; 142:771-6.
11. Shibata S, Sasaki T, Hirabayashi Y et al. Risk factors in the pregnancy of patients with systemic lupus erythematosus: Association of hypocomplementia with poor prognosis. Ann Rheum Dis 1992; 51:619-23.
12. Kutteh WH, Lyda EC, Abraham SM, Wacholtz MC. Association of anticardiolipin antibodies and pregnancy loss in women with systemic lupus erythematosus. Fertil Sterii 1993;60:449-55.
13. Packham DK, Lam SS, Nicholls K, Fairley KF, Kincaid-Smith PS. Lupus nephritis and pregnancy. Q J Med 1992;300:315-24.
14. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR. Outcome of treated pregnancies in women with antiphosholipid syndrome: An update of the Utah experience. Obstet Gynecol 1992; 80:614-20.
15. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725-34.
16. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999;42:1309-11.
17. Lê Thi Huong D, Wechsler B, Vauthier-Brouzes D et al. Outcome of planned pregnancies in systemic lupus erythematosus. A prospective study of 62 pregnancies. Br J Rheumatol 1997;36:772-7.
18. Yoon BH, Lee CM, Kim SW. An abnormal umbilical artery waveform: A strong and independent predictor of adverse perinatal outcome in patients with preeclampsia. Am J Obstet Gynecol 1994; 171:713-21.
19. Delle Chiaie L, Gramellini D, Piantelli G, Manotti C, Fieni S, Vadora E. Doppler velocimetry and thrombophilic screening at middle trimester gestation: Preliminary data. Eur J Obstet Gynecol Reprod Biol 2001;99:38-16.
20. Branch DW. Thoughts on the mechanism of pregnancy loss associated with the antiphospholipid syndrome. Lupus 1994;3:275-80.
21. Julkunen H. Renal lupus in pregnancy. Scand J Rheumatol 1998; 27(Suppl 107):80-3.
22. Backos M, Rai R, Baxter N, Chilcott IT, Cohen H, Regan L. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol 1999; 106:102-7.
23. Lê Thi Huong D, Wechsler B, Bletry O, Vauthier-Brouzes D, Lefebvre G, Piette JC. A study of 75 pregnancies in patients with the antiphospholipid syndrome. J Rheumatol 2001;28:2025-30.
24. Caruso A, De Carolis S, Ferrazzani S, Valesini G, Caforio L, Mancuso S. Pregnancy outcome in relation to uterine artery flow velocity waveforms and clinical characteristics in women with antiphospholipid syndrome. Obstet Gynecol 1993;82:970-7.
25. Benifla JL, Tchobroutsky C, Uzan M, Sultan Y, Weill BJ, Laumond-Barny S. Predictive value of uterine artery velocity waveforms in pregnancies complicated by systemic lupus erythematosus and the antiphospholipid syndrome. Fetal Diagn Ther 1992;7: 195-202.
26. Venkat-Raman N, Backos M, Teoh TG, Lo WT, Regan L. Uterine artery Doppler in predicting pregnancy outcome in women with antiphospholipid syndrome. Obstet Gynecol 2001;98:235-42.
27. Kerslake S, Morton KE, Versi E et al. Early Doppler studies in Lupus pregnancy. Am J Reprod Immunol 1992;28:172-5.
28. Carmona F, Font J, Azulay M et al. Risk factors associated with fetal losses in treated antiphospholipid syndrome pregnancies: A multivariate analysis. Am J Reprod Immunol 2001;46:274-9.
29. Nelson-Piercy C, Letsky EA, de Swiet M. Low molecular weight heparin for obstetric thromboprophylaxis: Experience of 69 pregnancies in 61 women at high risk. Am J Obstet Gynecol 1997; 176:1062-8.
30. Bar J, Mashiah R, Cohen-Sacher B et al. Effect of thrombophylaxis on uterine and fetal circulation in pregnant women with a history of pregnancy complications. Thromb Res 2001;101:235-41.
31. Crowther MA, Spitzer K, Julian J et al. Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients. A prospective cohort study. Thromb Res 2000;98:133-8.